National Biologics Manufacturing Centre
A state-of-the-art facility dedicated to boosting the UK’s manufacturing capability in biologics.
![A photo of the National Biologics Manufacturing Centre A photo of the National Biologics Manufacturing Centre](https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/national-biologics-01.jpg?w=1920&h=1080&q=60&fm=jpg&fit=crop&dm=1559211840&s=cc8dfd32c18ba50b4c359d405de94abd 1920w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/national-biologics-01.jpg?w=1120&h=630&q=60&fm=jpg&fit=crop&dm=1559211840&s=8709de745066691bb2dd5de7fde7ca4d 1120w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/national-biologics-01.jpg?w=800&h=450&q=60&fm=jpg&fit=crop&dm=1559211840&s=8090fa9ae9e7c67b5a5898341f3c1838 800w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/national-biologics-01.jpg?w=1600&h=900&q=45&fm=jpg&fit=crop&dm=1559211840&s=286b6cf15e3fdd00557c95989e882f13 1600w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/national-biologics-01.jpg?w=480&h=270&q=60&fm=jpg&fit=crop&dm=1559211840&s=3443a2c33759d109e37ad1e38ecec51e 480w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/national-biologics-01.jpg?w=960&h=540&q=45&fm=jpg&fit=crop&dm=1559211840&s=005fffac5b2bae96952be976edd0b34c 960w)
Cutting-edge biomedical innovation
The National Biologics Manufacturing Centre aims to significantly increase the UK’s manufacturing capability in biologics. The centre provides the facilities and extensive expertise to bridge the gap between academia and business, helping to turn great ideas into commercial reality. The £38 million centre promotes industry collaboration across the supply chain, from research through to manufacture and commercialisation.
![A placeholder image A placeholder image](https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/national-biologics-02.jpg?w=1920&h=1080&q=60&fm=jpg&fit=crop&dm=1559211843&s=c9a76b14dfc2615f2890638dc00f91cb 1920w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/national-biologics-02.jpg?w=1120&h=630&q=60&fm=jpg&fit=crop&dm=1559211843&s=570a29c2458a3396d0e6e665a6c01325 1120w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/national-biologics-02.jpg?w=800&h=450&q=60&fm=jpg&fit=crop&dm=1559211843&s=f410b48357405bb17928b54348382bca 800w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/national-biologics-02.jpg?w=1600&h=900&q=45&fm=jpg&fit=crop&dm=1559211843&s=367d1b1d6f2aa6f654736375108f1a84 1600w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/national-biologics-02.jpg?w=480&h=270&q=60&fm=jpg&fit=crop&dm=1559211843&s=0ba9725cd2c54738eb5d38c266fa3081 480w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/national-biologics-02.jpg?w=960&h=540&q=45&fm=jpg&fit=crop&dm=1559211843&s=0244920a45a48e66e228019b0952b50a 960w)
Novel ideas become commercial reality
Biologics are medicines produced from biological sources such as proteins and DNA. They represent the forefront of biomedical research, exhibiting excellent selectivity and enabling the development of personalised treatments. Biologics are providing alternative routes of treatment in disease areas with unmet clinical needs, including cancer, auto-immune conditions and neurological disorders. These medicines currently account for 10% to 15% of the global pharmaceutical market, a number that is rising steadily. The National Biologics Manufacturing Centre enables the UK to expand its contribution to the high-value production of biologics.
![A placeholder image A placeholder image](https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/biotherapeutics-analytical-image.jpg?w=1920&h=1080&q=60&fm=jpg&fit=crop&dm=1559218275&s=538a99bf025e3ed4784f5c02c4f6bf97 1920w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/biotherapeutics-analytical-image.jpg?w=1120&h=630&q=60&fm=jpg&fit=crop&dm=1559218275&s=253caff76abd1eda99d38d3cb0a9c85c 1120w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/biotherapeutics-analytical-image.jpg?w=800&h=450&q=60&fm=jpg&fit=crop&dm=1559218275&s=2a237a355e56bee501cd4e7812d2d019 800w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/biotherapeutics-analytical-image.jpg?w=1600&h=900&q=45&fm=jpg&fit=crop&dm=1559218275&s=75905a15ad665ab28a8aa9b60d9bfee4 1600w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/biotherapeutics-analytical-image.jpg?w=480&h=270&q=60&fm=jpg&fit=crop&dm=1559218275&s=3d0374e304bf6f39f8de5a3d1751cffb 480w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/biotherapeutics-analytical-image.jpg?w=960&h=540&q=45&fm=jpg&fit=crop&dm=1559218275&s=c42d66ff86b0f042c7f0929b5a6214df 960w)
State-of-the-art facilities and in-house expertise
The centre is designed to provide a space for the development of innovative new treatments and processes. Its flexible facilities include microbial and mammalian platforms with the ability to scale up processes from millilitres up to 200 litres. In addition, technologies are provided to enhance formulation, fill and finish. The site also includes GMP-capable environments for process, analytical and technology development. With the added value of in-house expertise, the National Biologics Manufacturing centre expands the biologic manufacturing capabilities of the UK, and enables innovative ideas to be brought to market faster, and with reduced risk.